Detail page

Knowledge Web

Person

Christoffer Clemmensen

Name	Christoffer Clemmensen
Time	2010- (Wirkungsdaten)
Place	Dänemark
Gender	männlich
Academic degree	Dr.
Related	Københavns Universitet Gesundheitswissenschaften (Thema)
Record type	Person
GND-Identifier	1260318842
Record ID	1260318842
Involved in show all GLP-1-directed NMDA receptor antagonism for obesity treatment Protection against overfeeding-induced weight gain is preserved in obesity but does not require FGF21 or MC4R An RNA-seq atlas of mouse brain areas during fasting and diet-induced obesity Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice ZAKβ is activated by cellular compression and mediates contraction‐induced MAP kinase signaling in skeletal muscle GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation Designing Poly-agonists for Treatment of Metabolic Diseases: Challenges and Opportunities Publisher Correction: Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese Gottingen minipigs GLP-1/glucagon receptor co-agonism for treatment of obesity Renaissance of leptin for obesity therapy Hypothalamic leptin action is mediated by histone deacetylase 5 Dual melanocortin‐4 receptor and GLP ‐1 receptor agonism amplifies metabolic benefits in diet‐induced obese mice

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Christoffer Clemmensen

GLP-1-directed NMDA receptor antagonism for obesity treatment

Protection against overfeeding-induced weight gain is preserved in obesity but does not require FGF21 or MC4R

An RNA-seq atlas of mouse brain areas during fasting and diet-induced obesity

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine

Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review

Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice

ZAKβ is activated by cellular compression and mediates contraction‐induced MAP kinase signaling in skeletal muscle

GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice

Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity

Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity

The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation

The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation

Designing Poly-agonists for Treatment of Metabolic Diseases: Challenges and Opportunities

Publisher Correction: Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes

Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases

Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes

Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese Gottingen minipigs

GLP-1/glucagon receptor co-agonism for treatment of obesity

Renaissance of leptin for obesity therapy

Hypothalamic leptin action is mediated by histone deacetylase 5

Dual melanocortin‐4 receptor and GLP ‐1 receptor agonism amplifies metabolic benefits in diet‐induced obese mice